Pharmafile Logo
Pharmafocus logo
Advanced Search
teva_copy

Teva’s Huntington’s treatment becomes first FDA-approved deuterated drug

April 4, 2017
Manufacturing and Production, Sales and Marketing Austedo, FDA, Teva

Israel’s Teva Pharmaceuticals has announced that the FDA has given its approval for Austedo (deutetrabenazine) in the treatment of chorea …

News
shutterstock_254160583

Sanofi to pay $20m fine for overcharging US veterans

April 4, 2017
Manufacturing and Production, Sales and Marketing Sanofi, Sanofi Pasteur, US

Sanofi Pasteur, the French firm’s vaccines unit, has agreed to pay a $19.8 million settlement over claims it overcharged the …

News
european_commission

Novartis combo expands into lung cancer with EU approval

April 4, 2017
Manufacturing and Production, Sales and Marketing NSCLC, Novartis, Tafinlar, mekinist

Novartis has announced that its Tafinlar (dabrafenib) and Mekinist (trametinib) drug combo has been approved by the European Commission (EC) …

News
robert_ring

Vencerx Therapeutics ring the changes appointing ex-Pfizer Director as CEO

April 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vencerx therapeutics

Vencerx Therapeutics, a biotech focused on developing treatments for neurodevelopmental disorders, has announced the appointment of Robert Ring as CEO. …

Appointment
rare_disease_day_logo

Behind Rare Disease Day 2017

April 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Rare Disease Day, rare disease

Rare Disease Day falls on the last day of February, meaning every four years it occurs on a leap year, …

Feature
blood-1813410_960_720

Finger-prick blood test could help with depression medication

April 3, 2017
Research and Development, Sales and Marketing

Researchers from the University of Texas Southwestern Medical Center have found that simple finger-prick blood test could reveal the most …

News
800px-university_of_pittsburgh_tablet2

Immune system influences immunotherapy effectiveness, research shows

April 3, 2017
Research and Development, Sales and Marketing immunotherapy, nivolumab, opdivo

Preliminary research conducted at the University of Pittsburgh Cancer Institute (UPCI) has discovered a link between levels of certain immune …

News

Pfizer secures expanded approval for Ibrance

April 3, 2017
Sales and Marketing Pfizer, ibrance

Pfizer has announced that FDA has approved its supplemental New Drug Application (sNDA) for Ibrance, meaning that the drug is …

News
1280px-epi-pen_1

FDA issues US-wide recall of Mylan’s EpiPen

April 3, 2017
Medical Communications, Sales and Marketing FDA, Mylan, epipen

After recent reports of around 80,000 defective EpiPen’s across Australia, New Zealand, Japan, Norway, Denmark, Finland and Ireland, the FDA …

News
astellas_tokyo_copy

Astellas lines up Ogeda for acquisition in $853 million deal

April 3, 2017
Sales and Marketing Astellas, Ogeda SA, menopause

Astellas, based in Tokyo, has announced that it has agreed a deal to acquire Belgium-based Ogeda SA. The deal will …

News

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

March 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI services

Introduction More than three years have passed since the US federal government signed the Drug Supply Chain Security Act (DSCSA) …

Feature
White paper
takeda_tokyo_hq

Takeda lays off more than half of Ariad’s US staff

March 31, 2017
Medical Communications Ariad Pharmaceuticals, Takeda

Takeda acquired Ariad Pharmaceuticals at the beginning on the year for $5.2 billion, a price many thought was relatively high …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s the end of the week, and the headlines were populated with stand-out stories that proved popular with our readers. …

News

FDA approves first-ever atopic dermatitis biologic treatment

March 31, 2017
Medical Communications, Sales and Marketing Dupixent, Regeneron, Sanofi, atopic dermatitis, biologic

Sanofi and Regeneron’s Dupixent (dupilumab) has become the first biologic medicine to be approved by the FDA for the treatment …

News
astrazeneca_sign_sky

AstraZeneca ends month with two pieces of news

March 31, 2017
Medical Communications, Sales and Marketing AstraZeneca, Tagrisso, TerSera Therapeutics, Zoladex

AstraZeneca has ended the month with more positive news on Tagrisso, that had previously been approved in China under its …

News
d2wtepzz

Changing levels of investment in UK drug discovery

March 31, 2017
Medical Communications, Research and Development ABPI, drug discovery, report

Key drug discovery investment trends

News
carb-x-interior-header

US and UK partnership to fund the fight against superbugs

March 31, 2017
Medical Communications, Research and Development CARB-X, Wellcome Trust

The cross-Atlantic partnership CARB-X, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, has announced that it would be funding 11 biotech companies …

News
giles_platford

Takeda names new President of Europe and Canada Business Unit

March 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment

Takeda has named Giles Platford as its new President of Europe and Canada (EUCAN) Business Unit as of 1 April, …

Appointment
paul-catchpole

Insider Interview: ABPI’s Paul Catchpole discusses NICE’s new fast-track appraisal system

March 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Insider Interview, NICE, Paul Catchpole, fast track

Paul Catchpole, Value and Access Director at the Association of the British Pharmaceutical Industry (ABPI), gives his thoughts on the …

Feature
fda2outsideweb

Trump’s FDA pick vows to sever past pharma ties to avoid partisanship

March 30, 2017
Medical Communications, Sales and Marketing FDA, Scott Gottlieb, Trump

After much speculation, Donald Trump recently announced his top pick for Commissioner of the FDA as Dr Scott Gottlieb. Gottlieb …

News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026